Volume 19, Issue 2

At the 20th Congress of ECCO in Stockholm, the Nurses of ECCO (N-ECCO) will host the educational activity for IBD Nurses, N-ECCO School, for the 16th time. ECCO intends to give nurses, who might be still in training and have an interest in IBD, the possibility to attend an IBD-focused course. The ultimate aim of this programme is to improve nurse education throughout Europe.

The 23rd ECCO IBD Intensive Course for Trainees designed for residents, fellows in gastroenterology and junior faculty will take place in Berlin, Germany, on February 19, 2025, immediately prior to our next Congress. We are pleased to inform you that the preliminary programme for this course is already available. Since ECCO wants to make the course as attractive as possible for participants, we limit the general number of participants for each ECCO Member Country to two, which will ensure a more interactive atmosphere. Three seats will be open for countries with a population of over...

We are pleased to introduce you to ECCO’s new Scientific Officer, Marietta Iacucci. Marietta is Professor of Gastroenterology at University College Cork and Consultant Gastroenterologist MUH/CUH. Marietta has been a very active member at ECCO for many years and is a main pillar in the e-learning taskforce. She is a Key opinion leader in Endoscopy and future technology in the field of IBD.

The first ECCO Global Grant was awarded at ECCO'24 to an international group leading a fascinating prospective study across Sub-Saharan Africa1. The study is focusing on IBD genetics in the region and is being led by Professor Nick Croft and Dr. Phoebe Hodges from Queen Mary University of London, Professor Paul Kelly and colleagues from the Tropical Gastroenterology and Nutrition Group, University of Zambia and Professor McGovern and his group at Cedars-Sinai, Los Angeles. I had the privilege of discussing aspects of the study with members of the study consortium.

During the last ECCO’24 Congress in Stockholm, the ECCO Governing Board announced the new strategy REACH. The REACH strategy is the acronym of five clear goals to shape the current and future ECCO activities for the next years, better defining and expanding ECCO global mission to improve the care for all IBD patients...

Change is the engine that propels scientific progress, and within this dynamic, committees evolve. As members transition, embracing fresh perspectives, the spirit of innovation flourishes, shaping the path ahead. Amidst this journey, EpiCom is pleased to introduce Paul Henderson while bidding farewell to Julien Kirchgesner.